(R)-N-(4-(3-((5-chloro-4-(1H-indol-3-yl)pyrimidin-2-yl)amino)piperidin-1-yl)-5-methoxy-2-methylphenyl)acrylamide

ID: ALA4872216

PubChem CID: 164619029

Max Phase: Preclinical

Molecular Formula: C29H31ClN6O2

Molecular Weight: 531.06

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  C/C=C/C(=O)Nc1cc(OC)c(N2CCC[C@@H](Nc3ncc(Cl)c(-c4c[nH]c5ccccc45)n3)C2)cc1C

Standard InChI:  InChI=1S/C29H31ClN6O2/c1-4-8-27(37)34-24-14-26(38-3)25(13-18(24)2)36-12-7-9-19(17-36)33-29-32-16-22(30)28(35-29)21-15-31-23-11-6-5-10-20(21)23/h4-6,8,10-11,13-16,19,31H,7,9,12,17H2,1-3H3,(H,34,37)(H,32,33,35)/b8-4+/t19-/m1/s1

Standard InChI Key:  ONZGVILAYLHELC-RRGNZLCHSA-N

Molfile:  

 
     RDKit          2D

 38 42  0  0  0  0  0  0  0  0999 V2000
    4.1282   -8.6676    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1270   -9.4950    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8420   -9.9080    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.5584   -9.4946    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5556   -8.6640    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.8401   -8.2547    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2737   -9.9060    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.9875   -9.4923    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6971   -9.9072    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4089   -9.4970    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.4118   -8.6715    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6968   -8.2580    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9788   -8.6697    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1226   -9.9111    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4149   -9.9103    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5208  -10.9018    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.3280  -10.7309    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1088  -10.1869    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6596   -9.5780    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4071   -8.7987    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6046   -8.6271    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0547   -9.2411    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3099  -10.0179    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4136   -8.2552    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    9.1172  -10.7356    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8300  -11.1497    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5465  -10.7386    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5457   -9.9093    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8322   -9.4990    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2607  -11.1518    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.9756  -10.7398    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6898  -11.1531    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9763   -9.9148    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.4047  -10.7412    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.1189  -11.1543    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8278  -11.9748    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8305   -8.6739    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.5443   -8.2598    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  4  7  1  0
  8  7  1  6
  8  9  1  0
  8 13  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 10 14  1  0
 15 19  1  0
 18 16  1  0
 16 17  1  0
 17 15  2  0
  2 15  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 18  1  0
  1 24  1  0
 14 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 14  1  0
 27 30  1  0
 30 31  1  0
 31 32  1  0
 31 33  2  0
 32 34  2  0
 34 35  1  0
 26 36  1  0
 29 37  1  0
 37 38  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4872216

    ---

Associated Targets(Human)

CDK2 Tchem CDK2/Cyclin A2 (2260 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CCNH Tbio Cyclin-dependent kinase 7/ cyclin H (714 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CCNT1 Tchem CDK9/cyclin T1 (2643 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CCNK Tbio CDK12/Cyclin K (892 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CDK13 Tchem Cyclin-dependent kinase 13/Cyclin-K (53 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 531.06Molecular Weight (Monoisotopic): 530.2197AlogP: 6.19#Rotatable Bonds: 7
Polar Surface Area: 95.17Molecular Species: NEUTRALHBA: 6HBD: 3
#RO5 Violations: 2HBA (Lipinski): 8HBD (Lipinski): 3#RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: 3.10CX LogP: 6.05CX LogD: 6.05
Aromatic Rings: 4Heavy Atoms: 38QED Weighted: 0.25Np Likeness Score: -1.16

References

1. Jiang B, Jiang J, Kaltheuner IH, Iniguez AB, Anand K, Ferguson FM, Ficarro SB, Seong BKA, Greifenberg AK, Dust S, Kwiatkowski NP, Marto JA, Stegmaier K, Zhang T, Geyer M, Gray NS..  (2021)  Structure-activity relationship study of THZ531 derivatives enables the discovery of BSJ-01-175 as a dual CDK12/13 covalent inhibitor with efficacy in Ewing sarcoma.,  221  [PMID:33945934] [10.1016/j.ejmech.2021.113481]

Source